You are about to leave the Clinical Value website now.

Cancel

Surveillance Imaging and Alpha Fetoprotein for Early Detection of Hepatocellular Carcinoma in Patients With Cirrhosis: A Meta-analysis

Quick Summary

This study aimed to compare the performance of surveillance imaging with or without alpha fetoprotein (AFP) for early detection of hepatocellular carcinoma (HCC) in patients with cirrhosis. The researchers searched MEDLINE and SCOPUS and found that ultrasound alone had low sensitivity for detecting early-stage HCC, but the addition of AFP significantly increased sensitivity. The study concluded that ultrasound plus AFP measurement is a more effective surveillance strategy for detecting HCC in clinical practice. However, only a few studies evaluated computed tomography or magnetic resonance image-based surveillance, which detected HCC with high sensitivity.

Authors: Kristina Tzartzeva, Joseph Obi, Nicole E. Rich, Neehar D. Parikh, Jorge A. Marrero, Adam Yopp, Akbar Waljee, Amit G. Singal

You May Also Like

13 September 2024

Empowering Precision Oncology: Leveraging digital solutions to facilitate molecular tumour board meetings and patient care management

Read More
19 August 2024

Pioneering Innovations in HCC Detection for Enhance Patient Outcomes – Chang Gung Memorial Hospital

Read More
19 August 2024

Strategic Efficiencies: Evaluating Cost-Effectiveness of Biomarker-Based HCC Surveillance

Read More

SHARE

Be the first to receive updates, event opportunities, and thought leadership insights.